Stimulating pharmaceutical research and development for neglected diseases
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Michael Kremer, 2001.
"Creating Markets for New Vaccines - Part II: Design Issues,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 1, pages 73-118,
National Bureau of Economic Research, Inc.
- Michael Kremer, 2000. "Creating Markets for New Vaccines Part II: Design Issues," NBER Working Papers 7717, National Bureau of Economic Research, Inc.
- Alan Williams, 2001. "Science or marketing at WHO? A commentary on ‘World Health 2000’," Health Economics, John Wiley & Sons, Ltd., vol. 10(2), pages 93-100, March.
- Michael Kremer, 2001.
"Creating Markets for New Vaccines - Part I: Rationale,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 1, pages 35-72,
National Bureau of Economic Research, Inc.
- Michael Kremer, 2000. "Creating Markets for New Vaccines Part I: Rationale," NBER Working Papers 7716, National Bureau of Economic Research, Inc.
- Lanjouw, Jean O. & Cockburn, Iain M., 2001. "New Pills for Poor People? Empirical Evidence after GATT," World Development, Elsevier, vol. 29(2), pages 265-289, February.
- Sievers, Allen M., 2000. "The indonesian economy, second edition1," Journal of Asian Economics, Elsevier, vol. 11(3), pages 359-362, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Claudimar Pereira Da Veiga & Cássia Rita Pereira Da Veiga & Jansen Maia Del Corso & Wesley Vieira Da Silva, 2015. "Dengue Vaccines: A Perspective from the Point of View of Intellectual Property," IJERPH, MDPI, vol. 12(8), pages 1-21, August.
- Driouchi, Ahmed, 2015. "New Health Technologies and Health Workforce in Developing Economies," MPRA Paper 67775, University Library of Munich, Germany.
- Munira, Syarifah Liza & Fritzen, Scott A., 2007. "What influences government adoption of vaccines in developing countries? A policy process analysis," Social Science & Medicine, Elsevier, vol. 65(8), pages 1751-1764, October.
- Mueller-Langer, Frank, 2013. "Neglected infectious diseases: Are push and pull incentive mechanisms suitable for promoting drug development research?," Health Economics, Policy and Law, Cambridge University Press, vol. 8(2), pages 185-208, April.
- Mueller-Langer, Frank, 2011. "Neglected infectious diseases: are push and pull incentive mechanisms suitable for promoting research?," MPRA Paper 40193, University Library of Munich, Germany.
- Forman, Rebecca & Azzopardi-Muscat, Natasha & Kirkby, Victoria & Lessof, Suszy & Nathan, Naomi Limaro & Pastorino, Gabriele & Permanand, Govin & van Schalkwyk, May CI & Torbica, Aleksandra & Busse, Re, 2022. "Drawing light from the pandemic: Rethinking strategies for health policy and beyond," Health Policy, Elsevier, vol. 126(1), pages 1-6.
- Srinivas, Smita, 2006. "Industrial Development and Innovation: Some Lessons from Vaccine Procurement," World Development, Elsevier, vol. 34(10), pages 1742-1764, October.
- Aerts, Céline & Sunyoto, Temmy & Tediosi, Fabrizio & Sicuri, Elisa, 2017. "Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature," Health Policy, Elsevier, vol. 121(7), pages 745-754.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Jean O. Lanjouw, 2003.
"Intellectual Property and the Availability of Pharmaceuticals in Poor Countries,"
NBER Chapters, in: Innovation Policy and the Economy, Volume 3, pages 91-130,
National Bureau of Economic Research, Inc.
- Jean O. Lanjouw, 2002. "Intellectual Property and the Availability of Pharmaceuticals in Poor Countries," Working Papers 5, Center for Global Development.
- de Walque, Damien, 2007.
"How does the impact of an HIV/AIDS information campaign vary with educational attainment? Evidence from rural Uganda,"
Journal of Development Economics, Elsevier, vol. 84(2), pages 686-714, November.
- De Walque, Damien, 2004. "How does the impact of an HIV/AIDS information campaign vary with educational attainment ? Evidence from rural Uganda," Policy Research Working Paper Series 3289, The World Bank.
- Jorge Marshall R., 2002. "El Camino de las Reformas," Notas de Investigación Journal Economía Chilena (The Chilean Economy), Central Bank of Chile, vol. 5(1), pages 77-82, April.
- Xavier Sala-i-Martin, 2002.
"15 Years of New Growth Economics : What Have we Learnt?,"
Journal Economía Chilena (The Chilean Economy), Central Bank of Chile, vol. 5(2), pages 5-15, August.
- Xavier Sala-i-Martin, 2001. "15 years of new growth economics: What have we learnt?," Economics Working Papers 620, Department of Economics and Business, Universitat Pompeu Fabra, revised Jun 2002.
- Xavier Sala-i-Martin, 2002. "15 Years of New Growth Economics: What Have We Learnt?," Working Papers Central Bank of Chile 172, Central Bank of Chile.
- Reto Foellmi & Josef Zweimuller, 2006.
"Income Distribution and Demand-Induced Innovations,"
The Review of Economic Studies, Review of Economic Studies Ltd, vol. 73(4), pages 941-960.
- Reto Foellmi & Josef Zweim�ller, "undated". "Income Distribution and Demand-induced Innovations," IEW - Working Papers 212, Institute for Empirical Research in Economics - University of Zurich.
- Zweimüller, Josef & Foellmi, Reto, 2005. "Income Distribution and Demand-Induced Innovations," CEPR Discussion Papers 4985, C.E.P.R. Discussion Papers.
- Ben van Hout & Jolian McHardy & Aki Tsuchiya, 2015. "Patent Purchase as a Policy for Pharmaceuticals," Working Papers 2015007, The University of Sheffield, Department of Economics.
- Yin, Wesley, 2008. "Market incentives and pharmaceutical innovation," Journal of Health Economics, Elsevier, vol. 27(4), pages 1060-1077, July.
- Agarwal, Ruchir & Gaule, Patrick, 2022.
"What drives innovation? Lessons from COVID-19 R&D,"
Journal of Health Economics, Elsevier, vol. 82(C).
- Agarwal, Ruchir & Gaule, Patrick, 2021. "What Drives Innovation? Lessons from COVID-19 R&D," IZA Discussion Papers 14079, Institute of Labor Economics (IZA).
- Ruchir Agarwal & Patrick Gaulé, 2021. "What Drives Innovation? Lessons from COVID-19 R&D," IMF Working Papers 2021/048, International Monetary Fund.
- Czarnitzki, Dirk & Toole, Andrew A., 2006. "Business R&D and the Interplay of R&D Subsidies and Market Uncertainty," ZEW Discussion Papers 06-055, ZEW - Leibniz Centre for European Economic Research.
- Kremer, Michael & Zwane, Alix Peterson, 2005. "Encouraging Private Sector Research for Tropical Agriculture," World Development, Elsevier, vol. 33(1), pages 87-105, January.
- Michael Kremer & Christopher M. Snyder, 2003. "Why Are Drugs More Profitable Than Vaccines?," NBER Working Papers 9833, National Bureau of Economic Research, Inc.
- Lakdawalla, Darius & Sood, Neeraj, 2009. "Innovation and the welfare effects of public drug insurance," Journal of Public Economics, Elsevier, vol. 93(3-4), pages 541-548, April.
- Yin, Wesley, 2009. "R&D policy, agency costs and innovation in personalized medicine," Journal of Health Economics, Elsevier, vol. 28(5), pages 950-962, September.
- Michael Kremer, 2002. "Pharmaceuticals and the Developing World," Journal of Economic Perspectives, American Economic Association, vol. 16(4), pages 67-90, Fall.
- Christine Greenhalgh & Padraig Dixon, 2002.
"The Economics of Intellectual Property: A Review to Identify Themes for Future Research,"
Economics Series Working Papers
135, University of Oxford, Department of Economics.
- Padraig Dixon & Christine Greenhalgh, 2003. "The Economics of Intellectual Property: A Review to Identify Themes for Future Research," Levine's Working Paper Archive 618897000000000645, David K. Levine.
- Boldrin Michele & Levine David K., 2009.
"Does Intellectual Monopoly Help Innovation?,"
Review of Law & Economics, De Gruyter, vol. 5(3), pages 991-1024, December.
- Michele Boldrin & David K Levine, 2009. "Does Intellectual Monopoly Help Innovation," Levine's Bibliography 814577000000000423, UCLA Department of Economics.
- Dirk Czarnitzki & Andrew Toole, 2007. "Business R&D and the Interplay of R&D Subsidies and Product Market Uncertainty," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 31(3), pages 169-181, November.
- Acharyya, Rajat & Garcia-Alonso, Maria D.C., 2006. "Self-interested international income redistribution and access to health care innovation," European Journal of Political Economy, Elsevier, vol. 22(2), pages 322-336, June.
- Lakdawalla, Darius & Sood, Neeraj, 2004. "Social insurance and the design of innovation incentives," Economics Letters, Elsevier, vol. 85(1), pages 57-61, October.
- Michael Kremer & Christopher Snyder, 2004. "Why is There No AIDS Vaccine?," CID Working Papers 111, Center for International Development at Harvard University.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:64:y:2003:i:1:p:75-88. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.